Ventilatory responses to metaboreflex activation in chronic obstructive pulmonary disease

Richard Bruce, Alice Turner, Michael White

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)
148 Downloads (Pure)


Blockade of thin fibre muscle afferent feedback during dynamic exercise reduces exercise hyperpnoea in health and chronic obstructive pulmonary disease (COPD). Therefore, we hypothesised that activation of the muscle metaboreflex at rest would cause hyperpnoea. To evaluate the effect of muscle metaboreflex activation on ventilation, in resting COPD patients and healthy participants. Following a bout of rhythmic hand grip exercise, post exercise circulatory occlusion (PECO) was applied to the resting forearm to sustain activation of the muscle metaboreflex, in 18 COPD patients (FEV1/FVC ratio < 70%), 9 also classified as chronically hypercapnic, and 9 age and gender matched controls. The cardiovascular response to exercise and the sustained blood pressure elevation during PECO was similar in patients and controls. During exercise ventilation increased by 6.64 ± 0.84 in controls and significantly (p < 0.05) more, 8.38 ± 0.81 l min−1 in patients. During PECO it fell to baseline levels in controls but remained significantly (p < 0.05) elevated by 2.78 ± 0.51 l min−1 in patients until release of circulatory occlusion, with no significant difference in responses between patient groups. Muscle metaboreflex activation causes increased ventilation in COPD patients but not in healthy participants. Chronic hypercapnia in COPD patients does not exaggerate this response. The muscle metaboreflex appears to be abnormally involved in the control of ventilation in COPD and may be a contributing factor to exercise dyspnoea.
Original languageEnglish
Pages (from-to)6025-6035
Number of pages11
JournalThe Journal of Physiology
Issue number20
Early online date12 May 2016
Publication statusPublished - 14 Jun 2016


Dive into the research topics of 'Ventilatory responses to metaboreflex activation in chronic obstructive pulmonary disease'. Together they form a unique fingerprint.

Cite this